Higher anti-CCP2 titers were observed in RA-ILD (77.9 versus 30.2, P < 0.001), whereas none of the patients with RA only had anti-CCP2 titers above 100 U/mL. This evidence concerns the gene AGBL2 and interstitial lung disease.